Leavell Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
14,486
-678
| -4% | -$47.4K | 0.05% | 300 |
|
|
2025
Q1 | $1.11M | Buy |
15,164
+6
| +0% | +$441 | 0.06% | 267 |
|
|
2024
Q4 | $993K | Sell |
15,158
-602
| -4% | -$39.4K | 0.05% | 280 |
|
|
2024
Q3 | $1.23M | Hold |
15,760
| – | – | 0.06% | 265 |
|
|
2024
Q2 | $1.23M | Buy |
15,760
+1,591
| +11% | +$124K | 0.07% | 241 |
|
|
2024
Q1 | $960K | Sell |
14,169
-3,094
| -18% | -$210K | 0.06% | 274 |
|
|
2023
Q4 | $1.16M | Buy |
17,263
+715
| +4% | +$48.2K | 0.07% | 232 |
|
|
2023
Q3 | $1.12M | Sell |
16,548
-531
| -3% | -$36K | 0.08% | 227 |
|
|
2023
Q2 | $1.22M | Hold |
17,079
| – | – | 0.08% | 222 |
|
|
2023
Q1 | $1.19M | Sell |
17,079
-3,186
| -16% | -$221K | 0.08% | 217 |
|
|
2022
Q4 | $1.37M | Sell |
20,265
-494
| -2% | -$33.5K | 0.1% | 193 |
|
|
2022
Q3 | $1.14M | Buy |
20,759
+1,494
| +8% | +$81.9K | 0.09% | 205 |
|
|
2022
Q2 | $1.27M | Hold |
19,265
| – | – | 0.1% | 191 |
|
|
2022
Q1 | $1.28M | Hold |
19,265
| – | – | 0.09% | 204 |
|
|
2021
Q4 | $1.12M | Sell |
19,265
-1,168
| -6% | -$68K | 0.07% | 224 |
|
|
2021
Q3 | $1.23M | Buy |
+20,433
| New | +$1.23M | 0.09% | 192 |
|
|
2021
Q1 | – | Sell |
-6,971
| Closed | -$348K | – | 393 |
|
|
2020
Q4 | $348K | Buy |
6,971
+1,667
| +31% | +$83.2K | 0.03% | 312 |
|
|
2020
Q3 | $291K | Sell |
5,304
-632
| -11% | -$34.7K | 0.03% | 320 |
|
|
2020
Q2 | $314K | Hold |
5,936
| – | – | 0.03% | 307 |
|
|
2020
Q1 | $265K | Buy |
+5,936
| New | +$265K | 0.03% | 303 |
|